DOI: 10.12890/2025_005098

Posterior reversible encephalopathy syndrome related to severe hypomagnesaemia

Authors

  • Martín Naya Rosato Internal Medicine Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
  • María Luisa Núñez Calvo Internal Medicine Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
  • Lucía Barrera López Internal Medicine Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Fundación Pública Galega, Instituto de Investigación Sanitaria de Santiago de Compostela, Spain

Martin.Naya.Rosato@sergas.es

Keywords

Dysarthria, hypomagnesaemia, hypokalaemia, posterior reversible encephalopathy syndrome

Abstract

Introduction: Posterior reversible encephalopathy syndrome (PRES) might be associated with a wide spectrum of symptoms, including irreversible neurological damage. Management is primarily symptomatic and focuses on addressing the underlying causes.
Case description: A 65-year-old female with a medical history of smoking, arterial hypertension and dyslipidaemia, was admitted due to dysarthria associated with ataxia, visual disturbances and diarrhoea. The neurological physical examination revealed a mild decreased strength in both legs (4/5), mild dysdiadochokinaesia and mild heel-knee dysmetria. Remarkable laboratory findings showed potassium 2.6 mmol/l and magnesium 0.24 mg/dl. Brain computed tomography (CT) showed no suggestive ischaemic areas. During hospitalisation, potassium and magnesium levels were initially corrected through intravenous supplementation. A brain magnetic resonance imaging (MRI) scan revealed symmetrical cortical alterations in the posterior regions of both cerebellar hemispheres, consistent with a diagnosis of PRES. After the exclusion of other potentially related diseases, the final diagnosis was PRES in the setting of severe hypomagnesaemia.
Discussion: PRES pathophysiology is unknown, while its incidence is probably underestimated. It is suggested that rapid increases in blood pressure are thought to overwhelm the self-regulatory capability of cerebral blood flow, especially in the posterior brain regions where the regulatory flow capacity may be weaker. This might result in increased cerebral perfusion leading to oedema due to capillary leakage. PRES has been associated with poorly controlled arterial hypertension, autoimmune diseases, eclampsia and chemotherapy, among others.
Conclusion: Hypomagnesaemia represents an uncommon but potentially reversible cause of PRES and should be taken into account for differential diagnosis.

View the entire article

Downloads

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500.
  2. Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015;14:914–925. Erratum in: Lancet Neurol 2015;14:874.
  3. Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol 2017;264:1608–1616.
  4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010;85:427–432.
  5. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–245.
  6. Almoussa M, Goertzen A, Brauckmann S, Fauser B, Zimmermann CW. Posterior reversible encephalopathy syndrome due to hypomagnesemia: a case report and literature review. Case Rep Med 2018;1980638.
  7. Ball AM, Rayi A, Gustafson M. A rare association of hypomagnesemia and posterior reversible encephalopathy syndrome (PRES). Cureus 2023;15: e41572.

Published

2025-01-10

How to Cite

1.
Naya Rosato M, Núñez Calvo ML, Barrera López L. Posterior reversible encephalopathy syndrome related to severe hypomagnesaemia. EJCRIM [Internet]. 2025 Jan. 10 [cited 2026 Nov. 3];12(2). Available from: https://ejcrim.com/index.php/ejcrim/article/view/5098

Most read articles by the same author(s)